2-tert-butylhydroquinone has been researched along with Bladder Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asakawa, E; Fukushima, S; Hagiwara, A; Kurata, Y; Shibata, MA | 1 |
| Fukushima, S; Hirose, M; Ito, N; Shirai, T; Tamano, S | 1 |
2 other study(ies) available for 2-tert-butylhydroquinone and Bladder Cancer
| Article | Year |
|---|---|
DNA synthesis and scanning electron microscopic lesions in renal pelvic epithelium of rats treated with bladder cancer promoters.
Topics: Animals; Ascorbic Acid; Bicarbonates; Butylated Hydroxyanisole; Butylated Hydroxytoluene; Carcinogens; Cyclic AMP; Dinoprostone; DNA; Epithelium; Ethoxyquin; Hydroquinones; Kidney Pelvis; Male; Microscopy, Electron, Scanning; Rats; Rats, Inbred F344; Sodium; Sodium Bicarbonate; Urinary Bladder Neoplasms | 1991 |
Modification by alpha-tocopherol, propyl gallate and tertiary butylhydroquinone of urinary bladder carcinogenesis in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Topics: Animals; Butylhydroxybutylnitrosamine; Cocarcinogenesis; Gallic Acid; Hydroquinones; Male; Nitrosamines; Propyl Gallate; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms; Vitamin E | 1987 |